XML 148 R29.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Segment Information (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2024
Segment Reporting [Abstract] |
Schedule of Operations by Reportable Segment | Approximate information concerning the Company’s operations by reportable segment for the three and six months ended June 30, 2024 and 2023 is as follows. The Company relies on intersegment cooperation and management does not represent that these segments, if operated independently, would report the results contained herein: Schedule of Operations by Reportable Segment
Three Months Ended June 30, 2024 |  | Product Packaging |  |  | Commercial Lending |  |  | Direct Marketing |  |  | Biotechnology |  |  | Securities |  |  | Corporate |  |  | Total |
Revenue |  | $ | 3,539,000 |  |  | $ | 44,000 |  |  | $ | 3,000 |  |  | $ | 1,000 |  |  | $ | 624,000 |  |  | $ | - |  |  | $ | 4,211,000 |
Cost of Revenue |  |  | 3,598,000 |  |  |  | (4,484,000 | ) |  |  | - |  |  |  | 10,000 |  |  |  | 2,066,000 |  |  |  | 4,483,000 |  |  |  | 5,673,000 |
Depreciation and amortization |  |  | 190,000 |  |  |  | - |  |  |  | 34,000 |  |  |  | 288,000 |  |  |  | 39,000 |  |  |  | 4,000 |  |  |  | 555,000 |
Interest expense |  |  | 45,000 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 1,199,000 |  |  |  | - |  |  |  | 1,244,000 |
Interest income |  |  | - |  |  |  | (1,000 | ) |  |  | 36,000 |  |  |  | 3,000 |  |  |  | 156,000 |  |  |  | 1,000 |  |  |  | 195,000 |
Net income (loss) from continuing operations |  |  | (894,000 | ) |  |  | 502,000 |  |  |  | 104,000 |  |  |  | (669,000 | ) |  |  | (2,566,000 | ) |  |  | (1,431,000 | ) |  |  | (4,954,000 | )
Capital expenditures |  |  | 29,000 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 29,000 |
Identifiable assets |  |  | 19,683,000 |  |  |  | 12,129,000 |  |  |  | 442,000 |  |  |  | 48,631,000 |  |  |  | 59,211,000 |  |  |  | 4,352,000 |  |  |  | 144,448,000 |
Assets held for sale |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 46,040,000 |  |  |  | - |  |  |  | 46,040,000 |
Three Months Ended June 30,2023 |  | Product Packaging |  |  | Commercial Lending |  |  | Direct Marketing |  |  | Biotechnology |  |  | Securities |  |  | Corporate |  |  | Total |
Revenue |  | $ | 3,626,000 |  |  | $ | 197,000 |  |  | $ | 1,572,000 |  |  | $ | - |  |  | $ | 1,838,000 |  |  | $ | - |  |  | $ | 7,233,000 |
Cost of Revenue |  |  | 2,421,000 |  |  |  | - |  |  |  | 516,000 |  |  |  | 2,000 |  |  |  | 1,820,000 |  |  |  | 73,000 |  |  |  | 4,832,000 |
Depreciation and amortization |  |  | 193,000 |  |  |  | - |  |  |  | 43,000 |  |  |  | 289,000 |  |  |  | 782,000 |  |  |  | 7,000 |  |  |  | 1,314,000 |
Interest expense |  |  | 47,000 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 91,000 |  |  |  | - |  |  |  | 138,000 |
Interest income |  |  | - |  |  |  | - |  |  |  | 280,000 |  |  |  | 49,000 |  |  |  | 78,000 |  |  |  |  |  |  |  | 407,000 |
Net income (loss) from continuing operations |  |  | (205,000 | ) |  |  | (1,213,000 | ) |  |  | (28,074,000 | ) |  |  | (3,934,000 | ) |  |  | (4,413,000 | ) |  |  | 116,000 |  |  |  | (37,723,000 | )
Capital expenditures |  |  | 4,000 |  |  |  | - |  |  |  | (4,000 | ) |  |  | 12,000 |  |  |  | 7,000 |  |  |  | - |  |  |  | 19,000 |
Identifiable assets |  |  | 23,080,000 |  |  |  | 41,324,000 |  |  |  | 7,159,000 |  |  |  | 49,952,000 |  |  |  | 71,610,000 |  |  |  | 9,619,000 |  |  |  | 202,744,000 |
Assets held for sale |  |  | - |  |  |  | - |  |  |  | 2,004,000 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 2,004,000 |
Six Months Ended June 30, 2024 |  | Product Packaging |  |  | Commercial Lending |  |  | Direct Marketing |  |  | Biotechnology |  |  | Securities |  |  | Corporate |  |  | Total |
Revenue |  | $ | 6,620,000 |  |  | $ | 146,000 |  |  | $ | 3,000 |  |  | $ | 2,000 |  |  | $ | 1,311,000 |  |  | $ | - |  |  | $ | 8,082,000 |
Cost of Revenue |  |  | 6,365,000 |  |  |  | (4,015,000 | ) |  |  | - |  |  |  | 20,000 |  |  |  | 3,810,000 |  |  |  | 4,483,000 |  |  |  | 10,663,000 |
Depreciation and amortization |  |  | 381,000 |  |  |  | - |  |  |  | 68,000 |  |  |  | 577,000 |  |  |  | 107,000 |  |  |  | 3,000 |  |  |  | 1,136,000 |
Interest expense |  |  | 91,000 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 2,299,000 |  |  |  | - |  |  |  | 2,390,000 |
Interest income |  |  | - |  |  |  | - |  |  |  | 72,000 |  |  |  | 9,000 |  |  |  | 219,000 |  |  |  | 2,000 |  |  |  | 302,000 |
Net income (loss) from continuing operations |  |  | (1,367,000 | ) |  |  | (880,000 | ) |  |  | 34,000 |  |  |  | (1,610,000 | ) |  |  | (4,915,000 | ) |  |  | (1,325,000 | ) |  |  | (10,063,000 | )
Capital expenditures |  |  | 29,000 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 29,000 |
Total Identifiable assets |  |  | 19,683,000 |  |  |  | 12,129,000 |  |  |  | 442,000 |  |  |  | 48,631,000 |  |  |  | 59,211,000 |  |  |  | 4,352,000 |  |  |  | 144,448,000 |
Assets held for sale |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 46,040,000 |  |  |  | - |  |  |  | 46,040,000 |
Six Months Ended June 30,2023 |  | Product Packaging |  |  | Commercial Lending |  |  | Direct Marketing |  |  | Biotechnology |  |  | Securities |  |  | Corporate |  |  | Total |
Revenue |  | $ | 9,661,000 |  |  | $ | 314,000 |  |  | $ | 5,566,000 |  |  | $ | - |  |  | $ | 3,523,000 |  |  | $ | - |  |  | $ | 19,064,000 |
Cost of revenue |  |  | 7,081,000 |  |  |  | - |  |  |  | 1,806,000 |  |  |  | 63,000 |  |  |  | 4,340,000 |  |  |  | 75,000 |  |  |  | 13,365,000 |
Depreciation and amortization |  |  | 381,000 |  |  |  | - |  |  |  | 89,000 |  |  |  | 586,000 |  |  |  | 1,526,000 |  |  |  | 65,000 |  |  |  | 2,647,000 |
Interest expense |  |  | 86,000 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 302,000 |  |  |  | - |  |  |  | 388,000 |
Interest income |  |  | - |  |  |  | - |  |  |  | 285,000 |  |  |  | 143,000 |  |  |  | 110,000 |  |  |  | - |  |  |  | 538,000 |
Net income (loss) from continuing operations |  |  | 491,000 |  |  |  | (1,777,000 | ) |  |  | (31,260,000 | ) |  |  | (4,782,000 | ) |  |  | (6,441,000 | ) |  |  | (2,588,000 | ) |  |  | (46,357,000 | )
Capital expenditures |  |  | 580,000 |  |  |  | - |  |  |  | - |  |  |  | 17,000 |  |  |  | 35,000 |  |  |  | (19,000 | ) |  |  | 613,000 |
Identifiable assets |  |  | 23,080,000 |  |  |  | 41,324,000 |  |  |  | 7,159,000 |  |  |  | 49,952,000 |  |  |  | 71,610,000 |  |  |  | 9,619,000 |  |  |  | 202,744,000 |
Assets held for sale |  |  | - |  |  |  | - |  |  |  | 2,004,000 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 2,004,000 |
Schedule of Disaggregation of Revenue | The following tables disaggregate our business segment revenues by major source: Printed Products Revenue Information: Schedule of Disaggregation of Revenue
Three months ended June 30, 2024 |  |  |  |
Packaging Printing and Fabrication |  | $ | 3,441,000 |
Commercial and Security Printing |  |  | 87,000 |
Total Printed Products |  | $ | 3,528,000 |
Three months ended June 30, 2023 |  |  |  |
Packaging Printing and Fabrication |  | $ | 3,571,000 |
Commercial and Security Printing |  |  | 55,000 |
Total Printed Products |  | $ | 3,626,000 |
Six months ended June 30, 2024 |  |  |  |
Packaging Printing and Fabrication |  | $ | 6,323,000 |
Commercial and Security Printing |  |  | 278,000 |
Total Printed Products |  | $ | 6,601,000 |
Six months ended June 30, 2023 |  |  |  |
Packaging Printing and Fabrication |  | $ | 9,341,000 |
Commercial and Security Printing |  |  | 320,000 |
Total Printed Products |  | $ | 9,661,000 |
Direct Marketing
Three months ended June 30, 2024 |  |  |  |
Direct Marketing Internet Sales |  | $ | - |
Total Direct Marketing |  | $ | - |
Three months ended June 30, 2023 |  |  |  |
Direct Marketing Internet Sales |  | $ | 1,572,000 |
Total Direct Marketing |  | $ | 1,572,000 |
Six months ended June 30, 2024 |  |  |  |
Direct Marketing Internet Sales |  | $ | - |
Total Direct Marketing |  | $ | - |
Six months ended June 30, 2023 |  |  |  |
Direct Marketing Internet Sales |  | $ | 5,566,000 |
Total Direct Marketing |  | $ | 5,566,000 |
Rental Income
Three months ended June 30, 2024 |  |  |  |
Rental income |  | $ | 438,000 |
Total Rental Income |  | $ | 438,000 |
Three months ended June 30, 2023 |  |  |  |
Rental income |  | $ | 1,543,000 |
Total Rental Income |  | $ | 1,543,000 |
Six months ended June 30, 2024 |  |  |  |
Rental income |  | $ | 838,000 |
Total Rental Income |  | $ | 838,000 |
Six months ended June 30, 2023 |  |  |  |
Rental income |  | $ | 3,228,000 |
Total Rental Income |  | $ | 3,228,000 |
Commission Income
Three months ended June 30, 2024 |  |  |  |
Commission income |  | $ | 204,000 |
Total commission income |  | $ | 204,000 |
Three months ended June 30, 2023 |  |  |  |
Commission income |  | $ | 295,000 |
Total commission income |  | $ | 295,000 |
Six months ended June 30, 2024 |  |  |  |
Commission income |  | $ | 507,000 |
Total commission income |  | $ | 507,000 |
Six months ended June 30, 2023 |  |  |  |
Commission income |  | $ | 295,000 |
Total commission income |  | $ | 295,000 |
Net Investment Income
Three months ended June 30, 2024 |  |  |  |
Net Investment Income |  | $ | 41,000 |
Total Investment Income |  | $ | 41,000 |
Three months ended June 30, 2023 |  |  |  |
Net Investment Income |  | $ | 197,000 |
Total Rental Income |  | $ | 197,000 |
Six months ended June 30, 2024 |  |  |  |
Net investment income |  | $ | 136,000 |
Total Management fee income |  | $ | 136,000 |
Six months ended June 30, 2023 |  |  |  |
Net Investment Income |  | $ | 314,000 |
Total Management fee income |  | $ | 314,000 |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration